Filing search / Incannex Healthcare Limited / "Classified"

PRE 14A

IXHL Incannex Healthcare Limited

31 Oct 24

Preliminary proxy

4:10pm

consists of five members, classified into three classes as follows: (1) Peter Widdows constitutes a class with a term ending at the Annual Meeting; (2) Dr … , 2024, Peter Widdows was nominated for election at the Annual Meeting. The board of directors currently consists of five members, classified into three

10-K

2024 FY

IXHL Incannex Healthcare Limited

30 Sep 24

Annual report

7:30am

(or that are synthesized versions of such substances), which are classified as controlled substances, as defined in the CSA. The CSA and its implementing … on synthetic cannabinoids and psilocybin, which are both currently classified as Schedule I controlled substances by the DEA. However, products that obtain

S-1/A

IXHL Incannex Healthcare Limited

17 Jul 24

IPO registration (amended)

8:47am

are approved by the FDA and classified as a Schedule II or III substance, an importer can import for commercial purposes if it obtains from the DEA … and restated certificate of incorporation provides that our board of directors is classified into three classes of directors, each with staggered three-year

S-1

IXHL Incannex Healthcare Limited

3 Jul 24

IPO registration

6:29am

. If any of our products are approved by the FDA and classified as a Schedule II or III substance, an importer can import for commercial purposes … securities. Our amended and restated certificate of incorporation provides that our board of directors is classified into three classes of directors

8-K

EX-99.1

IXHL Incannex Healthcare Limited

29 Nov 23

Entry into a Material Definitive Agreement

4:36pm

. Under the DGCL, unless otherwise provided in the Certificate of Incorporation, directors serving on a classified board may be removed … for a classified board of directors (the election and term of our directors); the provisions regarding removal of directors; the provisions regarding filling

8-K

f78 gxlzc59ypj

29 Nov 23

Entry into a Material Definitive Agreement

4:36pm

6-K

EX-99.1

68f4 fi01hghw42djqu

26 Oct 23

Incannex Healthcare September 2023 Quarterly Activities Report and Appendix 4C Cash Flow Statement

6:02am

6-K

EX-99.1

1j942m 15ywef6h

1 Sep 23

Report of Foreign Private Issuer

12:00am

6-K

EX-99.1

v0g c4h9ph

27 Jul 23

Incannex Healthcare June 2023 Quarterly Activities Report and Appendix 4C Cash Flow Statement

8:47pm

6-K

EX-99.1

vd2ctv03ikjzj9

26 Apr 23

Incannex Healthcare March 2023 Quarterly Activities Report and Appendix 4C Cash Flow Statement

9:40pm

20-F

salbwj

28 Oct 22

Annual report (foreign)

6:31am

6-K

EX-99.1

4w6suh

19 Sep 22

Report of Foreign Private Issuer

9:38pm

6-K

EX-99.1

gp3yn4st9kyfcqmf

1 Sep 22

Report of Foreign Private Issuer

6:13am

6-K

EX-99.1

v2dq62gn

28 Jul 22

Incannex Healthcare Quarterly Activities Report and Appendix 4C

2:35pm

6-K

EX-99.1

2htbhkhpd1 sy

28 Apr 22

Quarterly Activities Report and Appendix 4C Cash Flow Statement

6:40am

6-K

EX-99.2

4hvymsb0uoht

4 Apr 22

Incannex to Acquire APIRx Pharmaceuticals USA, LLC

6:07am

20FR12B/A

836sqz7tj

24 Feb 22

Initial registration of securities (foreign private issuers) (amended)

3:42pm

20FR12B/A

858n ufog

22 Feb 22

Initial registration of securities (foreign private issuers) (amended)

6:10am

20FR12B

5wyamcodhssotex

24 Jan 22

Initial registration of securities (foreign private issuers)

8:18pm